Durham, NC, United States of America

Daniel David Sternbach


Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Daniel David Sternbach: Innovator in Therapeutic Compounds

Introduction

Daniel David Sternbach is a prominent inventor based in Durham, North Carolina. With a total of four patents to his name, he has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel therapeutic compounds.

Latest Patents

Among his latest patents is a groundbreaking invention focused on thiazole and oxazole derivatives as activators of human peroxisome proliferator-activated receptors. This invention provides a compound of a specific formula that could potentially have various applications in therapeutic treatments, showcasing Sternbach's commitment to innovative solutions in medicine.

Career Highlights

Sternbach is currently associated with SmithKline Beecham Corporation, where he continues to push the boundaries of pharmaceutical research and development. His work at the corporation highlights his expertise in creating compounds that enhance human health and well-being.

Collaborations

Throughout his career, Daniel has had the opportunity to collaborate with several talented individuals, including Millard Hurst Lambert, III and Marcos Sznaidman. These professional relationships contribute to a rich environment of innovation and discovery, further advancing the potential of their collective research.

Conclusion

In conclusion, Daniel David Sternbach is an influential figure in the realm of drug development, marked by his innovative patents and collaborative efforts. His work at SmithKline Beecham Corporation not only underscores his expertise but also reflects a commitment to enhancing human health through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…